Skip to main content
Figure 2 | Reproductive Biology and Endocrinology

Figure 2

From: The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study

Figure 2

Plasma concentration-time profile of each individual and mean increases of immunoreactive FSH after abdominal and vaginal subcutaneous injections of 425 IU recombinant human FSH in twelve women under pituitary down-regulation with GnRH-agonist. Compared to baseline FSH level, significant differences were noted at 1 to 24 hours of vaginal injections and at 1 to 48 hours of abdominal injections (Table 5 & 6, See Additional files 5 &6).

Back to article page